TFS Capital’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-54,355
Closed -$881K 15
2017
Q2
$881K Buy
54,355
+3,982
+8% +$63K 0.35% 79
2017
Q1
$874K Sell
50,373
-8,103
-14% -$135K 0.28% 115
2016
Q4
$986K Sell
58,476
-57,108
-49% -$952K 0.26% 130
2016
Q3
$2.03M Buy
115,584
+73,487
+175% +$1.19M 0.49% 7
2016
Q2
$605K Sell
42,097
-136,685
-76% -$1.71M 0.11% 328
2016
Q1
$2.2M Buy
178,782
+26,257
+17% +$290K 0.32% 39
2015
Q4
$1.85M Sell
152,525
-31,273
-17% -$385K 0.2% 180
2015
Q3
$2.42M Buy
183,798
+48,971
+36% +$739K 0.23% 120
2015
Q2
$2.21M Buy
134,827
+124,349
+1,187% +$2.06M 0.22% 128
2015
Q1
$186K Sell
10,478
-88,736
-89% -$1.65M 0.02% 790
2014
Q4
$1.89M Buy
99,214
+8,138
+9% +$138K 0.18% 155
2014
Q3
$1.25M Buy
91,076
+75,522
+486% +$1.08M 0.11% 299
2014
Q2
$254K Sell
15,554
-90,445
-85% -$1.31M 0.02% 886
2014
Q1
$1.67M Sell
105,999
-199,292
-65% -$3.25M 0.11% 268
2013
Q4
$5.24M Buy
305,291
+188,543
+161% +$2.9M 0.25% 97
2013
Q3
$1.54M Buy
116,748
+94,453
+424% +$1.11M 0.07% 421
2013
Q2
$251K Buy
+22,295
New +$237K 0.01% 1224

Other funds holding ANGO

TFS Capital's ANGO Position: Q3 2017 in Review

TFS Capital sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 54,355 shares — an estimated $881K sold.

TFS Capital first reported a position in ANGO in Q2 2013 and held it in 17 quarters. The position peaked at $5.24M in Q4 2013. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

  • TFS Capital reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 54,355 AngioDynamics shares in Q3 2017, an estimated $881K.
  • TFS Capital first reported a position in AngioDynamics in Q2 2013 and held it in 17 quarters.
  • TFS Capital's AngioDynamics position peaked at $5.24M in Q4 2013.
  • 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.